Skip to content

AstraZeneca

US · AZN #68 by market cap Listed 1970
158.78 -1.34 -0.84%
Live - 5344 symbols - heartbeat 239s ago · 2026-10-08 18:12
Pre-market 159.78 -0.21%
After-hours 159.00 +0.14%
Overnight 159.44 -0.42%
Market cap
246.25B
P/B
4.90
EPS
6.54
Reader sentiment Are you bullish or bearish on AZN?

Anonymous reader poll. Unscientific, not investment advice.

About AstraZeneca

AstraZeneca is a biopharmaceutical company focused on oncology, rare diseases, and a biopharmaceuticals group spanning cardiovascular, renal and metabolic disease and respiratory and immunology treatments. It traces to 1913 and is headquartered in Cambridge, England.

Founded
1913
CEO
Mr. Pascal Soriot
Employees
94,300
Headquarters
Cambridge, Cambridgeshire, United Kingdom of Great Britain and Northern Ireland (the)
Fiscal year end
12-31
Website
astrazeneca.com

Company profile

Exchange
US
Symbol
AZN
Market-cap rank
#68
Listing date
1970-01-01
Market cap
246.25B
Float cap
244.96B
Shares out
1.55B
Float shares
1.54B

Sectors & themes

Infectious Disease Drug Manufacturers - General Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 18:12:31 · For reference only, not investment advice and not tailored to your situation.